Bohai Pharmaceuticals launches new corporate website

Bohai Pharmaceuticals Group, Inc. (OTCBB/OTCQB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announces the launch of a new corporate website for U.S. investors.

"We are pleased to announce the launch of our new website," said Mr. Hongwei Qu, President and Chief Executive Officer of Bohai Pharmaceuticals Group. "Our previous website has been completely re-designed from the ground up to provide for a high-quality user experience tailored toward our predominately western audience of U.S.-based investors. As Bohai implements our focused corporate growth strategy, we remain committed to providing our shareholders with updates on our progress through standard channels such as press releases, as well as upcoming investor material and multimedia assets made available through our website."

The corporate website provides an overview of Bohai Pharmaceuticals' business model and the company's various opportunities in China's healthcare market, and will prove an important resource for existing shareholders and prospective investors alike.